Laura Andrea
Charola Ramos
Investigadora
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Canarias (44)
2024
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
Alimentary Pharmacology and Therapeutics
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology
2023
-
COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire
Gastroenterologia y Hepatologia, Vol. 46, Núm. 4, pp. 255-260
-
Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
Frontiers in Medicine
-
Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients' Follow-Up Care during the COVID-19 Pandemic
Digestive Diseases, Vol. 41, Núm. 4, pp. 574-580
-
Hematological Composite Scores in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients
Inflammatory bowel diseases, Vol. 29, Núm. 7, pp. 1165-1169
-
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series
Journal of Crohn's & colitis, Vol. 17, Núm. 7, pp. 1097-1102
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
International journal of molecular sciences, Vol. 24, Núm. 6
2022
-
Adherence to subcutaneous biologic treatment for inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 335-341
-
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
Clinical and translational gastroenterology, Vol. 13, Núm. 6, pp. e00500
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Predictive factors for inadequate bowel cleansing in colon capsule endoscopy
Gastroenterologia y Hepatologia, Vol. 45, Núm. 8, pp. 605-613
-
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 668-676
-
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
Digestive and Liver Disease, Vol. 54, Núm. 5, pp. 635-641
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15